设为首页 加入收藏

TOP

第一款银屑病组合乳液halobetasol propionate/tazarotene(商品名 Duobrii)获FDA批准上市(三)
2019-04-27 15:00:22 来源: 作者: 【 】 浏览:2392次 评论:0
Cushing's syndrome, a condition from too much exposure to the hormone cortisol
High blood sugar (hyperglycemia)
Effects of growth and weight in children
Skin irritation. If you get too much skin irritation at the site of application, your healthcare provider may tell you to interrupt or stop using DUOBRII or to use it less often.
Vision problems, including an increased chance of developing cataracts and glaucoma. Tell your healthcare provider about any vision problems during treatment.
The most common side effects of DUOBRII Lotion include: redness, itching, swelling, burning, stinging, application site pain, inflamed hair follicles (folliculitis), thinning of the skin (atrophy), peeling and rash. 
Tags: 责任编辑:admin
首页 上一页 1 2 3 下一页 尾页 3/3/3
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇依那西普第二款生物仿制药etanerc.. 下一篇糖尿病口服新药semaglutide向欧洲..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位